{
  "package" : "hl7.terminology.r5@6.3.0",
  "definition" : "Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2\\r\\n\\r\\n\\\\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\\\\]\\r\\n\\r\\n\\\\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\\\\]\\r\\n\\r\\n\\\\[Note 3: This class also indicates a \\\"buffer zone,\\\" to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\\\\]\\r\\n\\r\\n\\\\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\\\]",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#status",
    "code" : "status",
    "valueCode" : "active"
  }, {
    "_uri" : "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id",
    "code" : "internalId",
    "valueCode" : "10221"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "subsumedBy",
    "valueCode" : "_ObservationInterpretationSusceptibility"
  } ],
  "codesystem" : "701017a8-e717-5351-8c56-15a0abeb863d",
  "concept_id" : "d530f314-5614-53c1-8d53-7837ca1dd62d",
  "ancestors" : {
    "I" : 0,
    "_ObservationInterpretationSusceptibility" : 1
  },
  "id" : "b895aad9-c957-4c67-8370-34428e2bce11",
  "code" : "I",
  "display" : "Intermediate",
  "version" : "3.0.0"
}